Terms: = Head and neck cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Staging
17 results:
1. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
Sang Y; Min R; Huang T; Zhang J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
[TBL] [Abstract] [Full Text] [Related]
2. ANXA2 as a novel substrate of FBXW7 promoting esophageal squamous cell carcinoma via erk phosphorylation.
Li Z; Pan Y; Yao J; Gao Y; Qian Y; Zheng M; Ma S
Biochem Biophys Res Commun; 2023 Mar; 649():93-100. PubMed ID: 36758484
[TBL] [Abstract] [Full Text] [Related]
3. Transcription factor ZNF488 accelerates cervical cancer progression through regulating the MEK/erk signaling pathway.
Weng K; Li L; Zhou H
Histol Histopathol; 2023 Dec; 38(12):1381-1390. PubMed ID: 36537752
[TBL] [Abstract] [Full Text] [Related]
4. The Myoepithelial Cells of Salivary Intercalated Duct-type Intraductal Carcinoma Are Neoplastic: A Study Using Combined Whole-slide Imaging, Immunofluorescence, and RET Fluorescence In Situ Hybridization.
Bishop JA; Rooper LM; Sangoi AR; Gagan J; Thompson LDR; Inagaki H
Am J Surg Pathol; 2021 Apr; 45(4):507-515. PubMed ID: 33086236
[TBL] [Abstract] [Full Text] [Related]
5. Poorly Differentiated Nonkeratinizing Squamous Cell Carcinoma of the Thymus: Clinicopathologic and Molecular Genetic Study of 25 Cases.
Suster D; Pihan G; Mackinnon AC; Suster S
Am J Surg Pathol; 2018 Sep; 42(9):1224-1236. PubMed ID: 29975245
[TBL] [Abstract] [Full Text] [Related]
6. Sclerosing microcystic adenocarcinoma of the tongue: a report of 2 further cases and review of the literature.
Wood A; Conn BI
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Apr; 125(4):e94-e102. PubMed ID: 29398516
[TBL] [Abstract] [Full Text] [Related]
7. Cytoplasmic collagen XIαI as a prognostic biomarker in esophageal squamous cell carcinoma.
Zhang B; Zhang C; Yang X; Chen Y; Zhang H; Liu J; Wu Q
Cancer Biol Ther; 2018 May; 19(5):364-372. PubMed ID: 29333916
[TBL] [Abstract] [Full Text] [Related]
8. DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.
Zhou Y; Wang L; Ban X; Zeng T; Zhu Y; Li M; Guan XY; Li Y
Oncogene; 2018 Feb; 37(8):1086-1094. PubMed ID: 29106393
[TBL] [Abstract] [Full Text] [Related]
9. HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features.
Bishop JA; Andreasen S; Hang JF; Bullock MJ; Chen TY; Franchi A; Garcia JJ; Gnepp DR; Gomez-Fernandez CR; Ihrler S; Kuo YJ; Lewis JS; Magliocca KR; Pambuccian S; Sandison A; Uro-Coste E; Stelow E; Kiss K; Westra WH
Am J Surg Pathol; 2017 Dec; 41(12):1690-1701. PubMed ID: 28877065
[TBL] [Abstract] [Full Text] [Related]
10. Trop2 enhances invasion of thyroid cancer by inducing MMP2 through erk and JNK pathways.
Guan H; Guo Z; Liang W; Li H; Wei G; Xu L; Xiao H; Li Y
BMC Cancer; 2017 Jul; 17(1):486. PubMed ID: 28709407
[TBL] [Abstract] [Full Text] [Related]
11. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
Garces S; Medeiros LJ; Patel KP; Li S; Pina-Oviedo S; Li J; Garces JC; Khoury JD; Yin CC
Mod Pathol; 2017 Oct; 30(10):1367-1377. PubMed ID: 28664935
[TBL] [Abstract] [Full Text] [Related]
12. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/erk Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract] [Full Text] [Related]
13. Calcium/Calmodulin-dependent protein kinase II and its endogenous inhibitor α in medullary thyroid cancer.
Russo E; Salzano M; De Falco V; Mian C; Barollo S; Secondo A; Bifulco M; Vitale M
Clin Cancer Res; 2014 Mar; 20(6):1513-20. PubMed ID: 24449826
[TBL] [Abstract] [Full Text] [Related]
14. Terbinafine inhibits KSR1 and suppresses Raf-MEK-erk signaling in oral squamous cell carcinoma cells.
Li B; Lu L; Zhong M; Tan XX; Liu CY; Guo Y; Yi X
Neoplasma; 2013; 60(4):406-12. PubMed ID: 23581412
[TBL] [Abstract] [Full Text] [Related]
15. MAPK/erk-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma.
Degen M; Natarajan E; Barron P; Widlund HR; Rheinwald JG
Am J Pathol; 2012 Jun; 180(6):2462-78. PubMed ID: 22546478
[TBL] [Abstract] [Full Text] [Related]
16. Circulating antibodies to p40(AIS) in the sera of respiratory tract cancer patients.
Yamaguchi K; Patturajan M; Trink B; Usadel H; Koch W; Jen J; Sidransky D
Int J Cancer; 2000 Nov; 89(6):524-8. PubMed ID: 11102898
[TBL] [Abstract] [Full Text] [Related]
17. PD 098059, an inhibitor of erk1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma.
Simon C; Hicks MJ; Nemechek AJ; Mehta R; O'Malley BW; Goepfert H; Flaitz CM; Boyd D
Br J Cancer; 1999 Jul; 80(9):1412-9. PubMed ID: 10424744
[TBL] [Abstract] [Full Text] [Related]
